NCT00975819 2026-01-06
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Boston Children's Hospital
Phase 2 Completed
Boston Children's Hospital
Palvella Therapeutics, Inc.
Stanford University
FDA Office of Orphan Products Development